A novel nanoconversion strategy was developed in this study, enabling the transformation of docetaxel (DTX) into a paclitaxel mimic (PTXm) that is specifically activated by tumor-specific cathepsin B enzymes. The gene discussed is CTSB; the disease is neoplasm.